Thyroid Cancers | Clinical

July 12, 2021

Marie E. Cabanillas, MD, discusses current unmet needs in advanced or metastatic TRK fusion-positive thyroid cancer.

June 27, 2021

The 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer expand on discussions about treatment goals and palliative care.

June 25, 2021

Lori Wirth, MD, discusses unmet needs and future considerations in the management of differentiated thyroid cancer.

June 25, 2021

Lori Wirth, MD, reviews key efficacy data from the post hoc analysis of the SELECT trial investigating the use of lenvatinib in patients with lung metastases.

June 25, 2021

An overview of how SELECT trial data affected clinical treatment practice for patients with differentiated thyroid cancer.

June 25, 2021

Medical oncologist Lori Wirth, MD, discusses treatment options for patients with radioiodine-refractory metastatic disease.

June 25, 2021

Lori Wirth, MD, discusses treatment options and potential adverse effects for differentiated thyroid cancer.

June 25, 2021

Lori Wirth, MD, provides an overview and diagnosis consideration of differentiated thyroid cancer and its related subtypes.

June 24, 2021

Many options are available for the treatment of RET-mutated thyroid cancer. During a Targeted Oncology Case-Based Roundtable event, Francis Paul Worden, MD, discussed the case of a 58-year-old patients who first presented with solitary nodule on the neck, occasional shortness of breath, and intermittent excessive fatigue.

June 06, 2021

Pediatric patients with advanced RET-altered solid tumors showed preliminary efficacy with selpercatinib, according to data presented at the 2021 ASCO Annual Meeting.